Potential benefit of ticagrelor monotherapy for patients with hypertension undergoing percutaneous coronary intervention: Insights from the Global Leaders trial
3 September 2019 (14:00 - 18:00)
Organised by:
Abstract
About the speaker
Boston Scientific Corporation, Maple Grove (United States of America)
9 More presentations in this session
Access the full session
The Event
ESC Congress 2019
3 September 2019
14:00 CET
